Search Clinical Trials

Clinical Trials Search Results

The results of your search are listed below. To view the details of a trial or study, click on the see details >> link. Or start a new search.

No search term entered

245 results total

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

See details >>

Principal Investigator: Robert Montgomery, MD

Study Number: 05-8538-V

Induction of Mixed Hematopoietic Chimerism in Patients with Severe Combined Immunodeficiency Disorders Using Allogeneic Bone Marrow from an HLA-Matched Related Donor and Post-Transplant Immunosuppression with Cyclosporine and Mycophenolate Mofetil

See details >>

Principal Investigator: Lauri Burroughs, MD

Study Number: 1227.00

A Pilot Study of High Dose Immunosuppression Followed by Infusion of CD34-Selected Autologous or Syngeneic Peripheral Blood Stem Cells for Treatment of Refractory Autoimmune Disorders

See details >>

Principal Investigator: Ann Woolfrey, MD

Study Number: 1353.00

A Phase II Trial Evaluating The Efficacy of Radioiodinated Tositumomab (anti-CD20) Antibody, Etoposide and Cyclophosphamide followed by Autologous Transplantation, for Relapsed or Refractory Non-Hodgkin's Lymphoma

See details >>

Principal Investigator: Ajay Gopal, MD

Study Number: 1368.00

A Phase I/II Study of Autologous Stem Cell Transplantation Followed by Non-Myeloablative Allogeneic Stem Cell Transplantation for Patients with Relapsed or Refractory Lymphoma - A Multi-Center Trial

See details >>

Principal Investigator: David Maloney, MD, PhD

Study Number: 1409.00

Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected with HIV-1 Using a Non-Marrow Ablative Conditioning Regimen Containing TBI in Combination with Post-Transplant Immunosuppression with Cyclosporine and Mycophenolate Mofetil

See details >>

Principal Investigator: Ann Woolfrey, MD

Study Number: 1410.00

Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplant for Patients with BCR-ABL Tyrosine Kinase Inhibitor Responsive Ph+ Acute Leukemia ? a Multi-Center Trial

See details >>

Principal Investigator: George Georges, MD

Study Number: 1581.00

A Feasibility Trial Combining Radiolabeled BC8 (Anti-CD45) Antibody with Fludarabine and Low Dose TBI Followed by Related or Unrelated PBSC Infusion and Post-Transplant Immunosuppression for Patients with Advanced AML or High Risk Myelodysplastic Syndrome

See details >>

Principal Investigator: John Pagel, MD, PhD

Study Number: 1809.00

Nonmyeloablative Conditioning with Pre- and Post-Transplant Rituximab followed by Related or Unrelated Donor Hematopoietic Cell Transplantation for Patients with Advanced Chronic Lymphocytic Leukemia: A Multi-Center Trial

See details >>

Principal Investigator: Mohamed Sorror, MD, MSc

Study Number: 1840.00

A Clinical Trial Evaluating I131-Tositumomab (anti-CD20) with Escalating Doses of Fludarabine followed by Autologous or Syngeneic Stem Cell Transplantation for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma in Patients 60 Years of Age and Older

See details >>

Principal Investigator: Ajay Gopal, MD

Study Number: 1943.00

Displaying first 10 of 245 total results. Click to view all 245 results.

Search Options

Select a disease from the list below:

Limit results to studies enrolling:
Both Adults & Pediatrics Adults Pediatrics

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.